UK Zika research awarded share of £120 million vaccine fund
21 November 2016
UK researchers creating new vaccines for epidemic diseases such as Zika and Ebola are among the winners of £22 million of funding, announced by the Department of Health today. These projects will be the first to benefit from the UK Vaccine Network, a £120 million fund launched last year to support Britain’s world-leading role fighting deadly diseases. The network brings together leading figures from industry, academia and philanthropy, including the Jenner Institute, University of Oxford, the Wellcome Trust, and GlaxoSmithKline (GSK).